mRNA-MD1

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamemRNA-MD1
Drug Alias Namemyotonic dystrophy program (Marina Biotech)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionMyotonin-protein kinase modulators
TargetsMyotonin-protein kinase
Therapy Area/IndicationsMyotonic Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdhera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdhera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMyotonic Dystrophy

Other Information

ATC CodeN/A
Related LinksN/A